The decision to stop the trial is based on a recommendation from the independent Data Monitoring Committee (DMC) concluding that the results from an interi...
Aidoc, a pioneer in clinical AI technology, and Mayo Clinic Platform are working together to improve care by providing access to Aidoc's AI technology and ...
Ad hoc announcement pursuant to Art. 53 LR Novartis executes separation of the Sandoz business to create an independent company by way of a 100% S...
AI-powered technology will expand access to scans by enabling a broader set of healthcare providers to perform cardiac exams with real-time guidance at t...
Historical Perspective Traditionally, the Middle East's economy has been heavily reliant on its vast reserves of oil and natural gas. However, the region'...
Activates Standard BioTools’ strategy to unlock value in underserved portion of $100 billion industry Establishes leading platform of mu...
Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the su...
QIAGEN announced the launch of its QuantiFERON-EBV RUO (Research Use Only) assay. Epstein-Barr virus (EBV), or human herpes virus 4, is estimated in ...
The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19 during the pandemic that began in ...
In a powerful display of solidarity with breast cancer warriors and patients, Avantor, a leading global supplier of products, services, and solutions for l...
"Today marks an exciting milestone for Danaher. The successful spin-off of Veralto as an independent company creates exceptional opportunities for both Dan...
“This partnership with Cardiac Imaging allows unprecedented access of RUBY Rubidium Elution System™ and RUBY-FILL® (Rubidium Rb82 generator...
The study will evaluate the safety, tolerability, and efficacy of SCI-210, in comparison to CBD monotherapy in treating ASD. Designed as a randomized, doub...
TOFIDENCE (BIIB800) becomes the first tocilizumab biosimilar to gain FDA approval in the United States FDA approval is based on a robust analytical, non...
© 2025 Biopharma Boardroom. All Rights Reserved.
